Joincare Pharmaceutical Group Industry Co.Ltd(600380) Pharmaceutical Group employee congress resolution announcement
Stock Code: Joincare Pharmaceutical Group Industry Co.Ltd(600380) securities abbreviation: Joincare Pharmaceutical Group Industry Co.Ltd(600380) Announcement No.: pro 2022044 Joincare Pharmaceutical Group Industry Co.Ltd(600380)
Announcement of the resolution of the workers’ Congress
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Joincare Pharmaceutical Group Industry Co.Ltd(600380) (hereinafter referred to as “the company”) the employee Congress meeting was held in conference room 3 of the company from 10:00 to 11:00 on April 22, 2022. The meeting was convened and presided over by the chairman of the trade union. The convening, convening and voting procedures of the meeting comply with the company law of the people’s Republic of China and the relevant provisions of the articles of association. After careful discussion by the staff representatives attending the meeting, the following resolutions are formed:
Deliberated and passed the proposal on the company’s phase II shareholding plan (Draft) of the shareholding plan of medium and long-term business partners and its summary
The contents of the second phase of the shareholding plan of the medium and long-term business partner shareholding plan implemented by the company comply with the provisions of relevant laws, regulations and normative documents. There is no situation that damages the interests of the company and all shareholders, and there is no situation that employees are forced to participate in the current phase of the shareholding plan by means of apportionment, forced distribution, etc. It is agreed that the company shall formulate the second phase of the shareholding plan of medium and long-term business partners (Draft) (hereinafter referred to as the current phase of the shareholding plan) and the summary.
The company’s implementation of the second phase of the medium and long-term partner shareholding plan can further improve the company’s governance structure, establish an effective incentive and restraint mechanism, enhance the company’s management and core employees’ sense of responsibility and mission to realize the sustainable and healthy development of the company, and effectively combine the interests of shareholders, the company and the personal interests of employees, which is conducive to the long-term development of the company.
It is hereby announced.
Joincare Pharmaceutical Group Industry Co.Ltd(600380) April 25, 2002
